Literature summary for 3.4.23.B4 extracted from

Laco G.S.; Schalk-Hihi C.; Lubkowski J.; Morris G.; Zdanov A.; Olson A.; Elder J.H.; Wlodawer A.; Gustchina A.
Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor (1997), Biochemistry, 36, 10696-10708.

Search for more literature for 3.4.23.B4

Crystallization (Commentary)

Crystallization (Comment)	Organism
complex of the D30N mutant enzyme with the statine-based inhibitor LP-149 as well as with a substrate based on a modification of the inhibitor, LP-149S	feline immunodeficiency virus

Protein Variants

Protein Variants	Comment	Organism
D30N	-	feline immunodeficiency virus
D30N	inactive mutant enzyme	feline immunodeficiency virus

Inhibitors

Inhibitors	Comment	Organism	Structure
LP-149	i.e. Ac-NA-Val-Sta-Glu-NA-NH2	feline immunodeficiency virus

Molecular Weight [Da]

Molecular Weight [Da]	Molecular Weight Maximum [Da]	Comment	Organism
13300	-	ionization mass spectrometry	feline immunodeficiency virus

Organism

Organism	UniProt	Comment	Textmining
feline immunodeficiency virus	P16088	-	-
feline immunodeficiency virus	P16088	isolate Petaluma	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)